Calcium channel blockers with predominant peripheral effects is:
Calcium channel blockers work by inhibiting calcium influx into cells. There are two main types: dihydropyridines (DHPs) like nifedipine, and non-dihydropyridines like verapamil and diltiazem. DHPs are more selective for vascular smooth muscle, leading to peripheral vasodilation. Non-DHPs have more cardiac effects, like reducing heart rate and contractility.
So the question is about peripheral effects. The correct answer should be a DHP. Let's say the options were A. Verapamil, B. Diltiazem, C. Nifedipine, D. Amlodipine. Then C or D would be correct. But the user didn't provide the options. Hmm, maybe I should use a standard example. Let's assume the correct answer is C. Nifedipine.
Now, why is Nifedipine correct? Because it's a DHP CCB with high selectivity for peripheral vasculature, causing vasodilation and lowering blood pressure. Non-DHPs like Verapamil and Diltiazem affect the heart more, so they're not the right answer. The clinical pearl here is that DHPs are used for hypertension and peripheral vascular disease, while non-DHPs are for arrhythmias and angina.
I need to make sure each section is covered: Core Concept, why correct, why others wrong, and a clinical pearl. Also, the correct answer line at the end. Keep it concise but thorough. Let me check if I missed any key terms or explanations. Maybe mention the receptors or mechanisms again. Also, ensure that the wrong options are clearly explained as incorrect. For example, Verapamil has more cardiac effects, so it's not peripheral. Diltiazem is similar. Amlodipine is a DHP but longer acting, but still peripheral. So if the options included Amlodipine and Nifedipine, both are DHPs, but maybe Nifedipine is more classic for peripheral effects. Need to clarify that if both are DHPs, but the question is about predominant peripheral effects. Maybe the correct answer is Nifedipine as the prototypical example. Alright, I think that's covered.
**Core Concept**
Calcium channel blockers (CCBs) are categorized into dihydropyridines (DHPs) and non-DHPs. DHPs like **nifedipine** predominantly target peripheral vascular smooth muscle, causing vasodilation, while non-DHPs like **verapamil** and **diltiazem** have stronger cardiac effects (e.g., reducing heart rate and contractility).
**Why the Correct Answer is Right**
Nifedipine is a DHP CCB with high selectivity for peripheral arterial smooth muscle. It inhibits **L-type calcium channels**, reducing intracellular calcium influx and causing vasodilation. This lowers systemic vascular resistance, making it ideal for hypertension and peripheral vascular disease. Its minimal effect on cardiac conduction contrasts with non-DHPs, which act on